Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTND4P18 (mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 18) is a nuclear-encoded pseudogene with homology to the mitochondrial MT-ND4 gene, which itself encodes a key subunit of complex I in the electron transport chain. Unlike MT-ND4, MTND4P18 has mutations preventing it from encoding a functional protein, so it does not participate in mitochondrial oxidative phosphorylation or any known cellular function, nor is it a therapeutic target[4].\n\nNote: If you intended to inquire about the functional mitochondrial MT-ND4 gene/protein (not the pseudogene), it is a component of complex I, critical for mitochondrial respiration, and is linked to mitochondrial diseases and has potential diagnostic implications[1][2][3]. The pseudogene variant (MTND4P18), however, is not a functional target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 pseudogene 18 (MTND4P18).